All Comments by Hiroshi Mori

  1. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a new group of tauopathies.
  2. Apolipoprotein E polymorphism in elderly east Africans.
  3. Generation of anti-apoptotic presenilin-2 polypeptides by alternative transcription, proteolysis, and caspase-3 cleavage.
  4. Amyloid angiopathy in a Volga German family with Alzheimer's disease and a presenilin-2 mutation (N141I).
  5. Melatonin prevents beta-amyloid-induced lipid peroxidation.
  6. Complement C1-inhibitor expression in Alzheimer's disease.
  7. Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red.
  8. Mutations in the transmembrane domain of APP altering gamma-secretase specificity.
  9. Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia.
  10. Apolipoprotein-E deficiency results in an altered stress responsiveness in addition to an impaired spatial memory in young mice.
  11. Mechanism of action of antiinflammatory drugs.
  12. Alpha-2 macroglobulin is genetically associated with Alzheimer disease.
  13. The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer's disease.
  14. Presenilin-1 mutations increase levels of ryanodine receptors and calcium release in PC12 cells and cortical neurons.
  15. Heparin-binding properties of the amyloidogenic peptides Abeta and amylin. Dependence on aggregation state and inhibition by Congo red.